Fundz

Aurora Cannabis Acquires MedReleaf Australia

PUBLIC · ACBFeb 08, 2024

Acquiring Company

Aurora Cannabis

Acquired Company

MedReleaf Australia

EdmontonBrisbaneManufacturingBiotechnologyAgriculture and FarmingHealth CareMedicalCannabisPharmaceutical Manufacturing

Description

Aurora Cannabis Inc., a leading global medical cannabis company based in Canada, has acquired the remaining approximately 90% equity interest of MedReleaf Australia. The acquisition is valued at AUD$50 million and is expected to provide a meaningful platform for Aurora to continue growing its leading global medical cannabis position in Australia and other APAC countries.

Quick answer

Aurora Cannabis is acquiring MedReleaf Australia, announced February 8, 2024. Aurora Cannabis is based in Edmonton, Alberta, Canada.

How much did Aurora Cannabis pay for MedReleaf Australia?
The deal value was not disclosed.
Where are Aurora Cannabis and MedReleaf Australia based?
Aurora Cannabis is based in Edmonton, Alberta, Canada. MedReleaf Australia is based in Brisbane, Queensland, Australia.
Who are the decision-makers at Aurora Cannabis?
Fundz holds 3 contacts at Aurora Cannabis. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Agriculture and Farming and Medical

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Aurora Cannabis, and when

When Aurora Cannabis changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Aurora Cannabis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aurora Cannabis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aurora Cannabis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aurora Cannabis

Location

Edmonton, Alberta, Canada

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aurora Cannabis makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Simona
Likely contact at this company
••••••••@••••••••

See Simona's verified email →

Sarah
Senior decision-maker at this company
••••••••@••••••••

See Sarah's verified email →

Pankaj
Senior decision-maker at this company
••••••••@••••••••

See Pankaj's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Aurora Cannabis's next move

Learn about Strategic plan

Frequently asked

Who acquired MedReleaf Australia?

MedReleaf Australia was acquired by Aurora Cannabis, based in Edmonton. The deal was reported on February 8, 2024. Aurora Cannabis is publicly traded (ACB) and operates in Manufacturing.

When did Aurora Cannabis acquire MedReleaf Australia?

Aurora Cannabis's acquisition of MedReleaf Australia was reported on February 8, 2024. Aurora Cannabis Inc., a leading global medical cannabis company based in Canada, has acquired the remaining approximately 90% equity interest of MedReleaf Australia. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does MedReleaf Australia do?

MedReleaf Australia is a leading distributor of medical cannabis products and holds the #2 position in the Australian medical cannabis market. The company has connected clinicians with patients nationwide and positively impacted thousands of lives. It is privately held, operating in Pharmaceutical Manufacturing, and is based in Brisbane.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.